Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

GEM144 is a dual inhibitor of DNA polymerase α (POLA1) and histone deacetylase 11 (HDAC11).1 It inhibits the primer extension activity of POLA1 in a cell-free assay when used at concentrations ranging from 10 to 50 µM and increases acetylation of α-tubulin at lysine 40 in H460 lung cancer cells at 0.4 µM. It inhibits proliferation in a panel of cancer cell lines, including three malignant melanoma (IC50s = 0.73-1.4 µM), six hematological (IC50s = 0.16-3.2 µM), one breast cancer (IC50 = 0.77 µM), and one glioma cell line (IC50 = 1 µM). GEM144 (50 mg/kg) reduces tumor growth in an H460 mouse xenograft model and an MM487 orthotopic, malignant pleural mesothelioma xenograft model.
WARNING This product is not for human or veterinary use.
1. Antitumor activity of novel POLA1-